From: Mid-term effect of balloon aortic valvuloplasty on mitral regurgitation in aortic stenosis
Baseline | 1 month after BAV | P value | 3 months after BAV | P value | |
---|---|---|---|---|---|
Clinical data | |||||
NYHA III/IV, n (%) | 28 (70.0) | 1 (2.5) | < 0.001 | 1 (2.5) | < 0.001 |
Laboratory data | |||||
BNP, pg/mL | 702 (391–1042) | 421 (206–618) | 0.002 | 281 (182–401) | < 0.001 |
Conventional echo parameters | |||||
LVEDD, mm | 46.2 ± 6.0 | 45.4 ± 6.5 | 0.237 | 44.0 ± 6.8 | 0.033 |
LVESD, mm | 32.6 ± 6.8 | 31.2 ± 7.7 | 0.148 | 28.6 ± 7.0 | < 0.001 |
LVEF, % | 51.4 ± 13.0 | 54.1 ± 10.1 | 0.089 | 57.4 ± 12.5 | 0.007 |
LVSVI, mL | 38.3 ± 11.7 | 41.3 ± 11.1 | 0.052 | 44.6 ± 11.2 | 0.002 |
E/A | 1.0 (0.6–1.6) | 0.7 (0.6–1.0) | 0.003 | 0.7 (0.5–0.9) | 0.001 |
E/e’ | 20.5 ± 8.7 | 15.5 ± 6.2 | < 0.001 | 16.1 ± 7bnp.1 | 0.002 |
TR-PG, mmHg | 40.5 ± 15.4 | 29.7 ± 8.4 | < 0.001 | 28.9 ± 6.4 | < 0.001 |
AR ≥ moderate, n (%) | 5 (12.5) | 6 (15.0) | 1.000 | 4 (10.0) | 1.000 |
AS parameters | |||||
AVA, cm2 | 0.66 ± 0.17 | 0.84 ± 0.19 | < 0.001 | 0.80 ± 0.20 | 0.001 |
AVAi, cm2/m2 | 0.47 ± 0.12 | 0.59 ± 0.12 | < 0.001 | 0.57 ± 0.12 | < 0.001 |
Peak V, m/s | 61.0 ± 27.1 | 45.0 ± 19.1 | < 0.001 | 51.7 ± 25.1 | 0.002 |
mPG (mmHg) | 35.6 ± 17.0 | 24.9 ± 11.5 | < 0.001 | 29.8 ± 15.2 | 0.003 |
MR parameters | |||||
MR jet area, cm2 | 6.3 (4.5–9.7) | 3.5 (1.5–7.4) | < 0.001 | 2.1 (1.1–6.0) | < 0.001 |
%MR, % | 33.3 (22.6–42.7) | 16.0 (8.9–34.3) | < 0.001 | 12.0 (4.7–29.4) | < 0.001 |
Mitral annular dimension, mm | 28.5 ± 4.9 | 27.2 ± 4.2 | 0.030 | 25.5 ± 3.3 | < 0.001 |
Tenting height, mm | 4.1 ± 1.9 | 3.8 ± 1.9 | 0.307 | 2.8 ± 1.1 | < 0.001 |
Tenting area, mm2 | 58.8 ± 31.6 | 52.0 ± 28.5 | 0.169 | 35.5 ± 14.5 | < 0.001 |